Lista de obras -

A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium

artículo científico publicado en 2012

A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

artículo científico publicado en 2014

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells

artículo científico publicado en 2013

A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells

artículo científico publicado en 2015

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.

artículo científico publicado en 2018

Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesis

artículo científico publicado en 2020

Biomarkers for bladder cancer management: present and future.

artículo científico publicado en 2014

Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer

artículo científico publicado en 2014

Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis

scientific article published on 26 November 2018

Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels

artículo científico publicado en 2015

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

artículo científico publicado en 2018

Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression

artículo científico publicado en 2011

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

artículo científico publicado en 2018

Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

artículo científico publicado en 2017

FBXW7 mutations in melanoma and a new therapeutic paradigm

artículo científico publicado en 2014

H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases

artículo científico publicado en 2015

Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression

artículo científico publicado en 2011

Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR

scientific article published on 03 July 2018

Immunopathologic Assessment of PTEN Expression

artículo científico publicado en 2016

Inactivation of p53 and Pten promotes invasive bladder cancer

artículo científico publicado en 2009

Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers

artículo científico publicado en 2015

Intragenic antagonistic roles of protein and circRNA in tumorigenesis

scientific article published on 17 June 2019

Limited miR-17-92 overexpression drives hematologic malignancies

artículo científico publicado en 2014

Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner

artículo científico publicado en 2013

Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria

artículo científico publicado en 2015

MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.

artículo científico publicado en 2015

Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma

artículo científico publicado en 2015

Molecular pathways of urothelial development and bladder tumorigenesis

artículo científico publicado en 2010

Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling

artículo científico publicado en 2016

PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer

artículo científico publicado en 2015

PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth

artículo científico publicado en 2017

Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia

artículo científico publicado en 2012

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy

artículo científico

RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis

artículo científico publicado en 2014

Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis

artículo científico publicado en 2015

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

artículo científico publicado en 2012

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

artículo científico publicado en 2008

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

artículo científico publicado en 2016

The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells

artículo científico publicado en 2014

The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

artículo científico publicado en 2017

Transformed bone marrow cells generate neoplasms of distinct histogenesis. a murine model of cancer transplantation

scientific article published on 05 November 2019

Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition

artículo científico publicado en 2016

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

artículo científico publicado en 2017

ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer

artículo científico publicado en 2014

Lista de obras de

A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium

A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells

A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.

Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesis

Biomarkers for bladder cancer management: present and future.

Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer

Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis

Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

FBXW7 mutations in melanoma and a new therapeutic paradigm

H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases

Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression

Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR

Immunopathologic Assessment of PTEN Expression

Inactivation of p53 and Pten promotes invasive bladder cancer

Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers

Intragenic antagonistic roles of protein and circRNA in tumorigenesis

Limited miR-17-92 overexpression drives hematologic malignancies

Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner

Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria

MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.

Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma

Molecular pathways of urothelial development and bladder tumorigenesis

Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling

PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer

PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth

Preclinical analysis of the γ-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy

RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis

Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells

The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

Transformed bone marrow cells generate neoplasms of distinct histogenesis. a murine model of cancer transplantation

Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

ΔNp63 expression is a protective factor of progression in clinical high grade T1 bladder cancer